Cargando…
Experimental PCEP-Adjuvanted Swine Influenza H1N1 Vaccine Induced Strong Immune Responses but Did Not Protect Piglets against Heterologous H3N2 Virus Challenge
Vaccination is the most efficient method of protection against influenza infections. However, the rapidly mutating viruses and development of new strains make it necessary to develop new influenza vaccines annually. Hence, vaccines that stimulate cross-protection against multiple influenza subtypes...
Autores principales: | Magiri, Royford Bundi, Lai, Ken John, Mutwiri, George Kiremu, Wilson, Heather Lynne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349969/ https://www.ncbi.nlm.nih.gov/pubmed/32443540 http://dx.doi.org/10.3390/vaccines8020235 |
Ejemplares similares
-
Caspase-1 Dependent IL-1β Secretion and Antigen-Specific T-Cell Activation by the Novel Adjuvant, PCEP
por: Awate, Sunita, et al.
Publicado: (2014) -
Polyphosphazenes as Adjuvants for Animal Vaccines and Other Medical Applications
por: Chand, Dylan J., et al.
Publicado: (2021) -
Kinome Analysis to Define Mechanisms of Adjuvant Action: PCEP Induces Unique Signaling at the Injection Site and Lymph Nodes
por: Awate, Sunita, et al.
Publicado: (2022) -
The Adjuvants Polyphosphazene (PCEP) and a Combination of Curdlan Plus Leptin Promote a Th17-Type Immune Response to an Intramuscular Vaccine in Mice
por: Chaffey, Alyssa, et al.
Publicado: (2021) -
PCEP enhances IgA mucosal immune responses in mice following different immunization routes with influenza virus antigens
por: Eng, Nelson F, et al.
Publicado: (2010)